GlassScriptPhysician profile
Alia Rezek
NPI 1699129239
$757.28
in general payments reported to CMS, 2019-2025
12 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.08 · 2022: $133 · 2023: $243 · 2024: $150 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $225.58 | 2022-2023 | |
| Pfizer INC. | $123.90 | 2021-2024 | |
| Biogen, INC. | $94.63 | 2025 | Zurzuvae |
| Axonics, INC. | $57.64 | 2024 | Bulkamid |
| Gilead Sciences, INC. | $54.35 | 2024 | |
| Mayne Pharma Commercial LLC | $38.64 | 2023 | |
| Astellas Pharma US INC | $33.55 | 2025 | Veozah |
| Shield Therapeutics INC | $33.14 | 2025 | |
| Exeltis, USA INC. | $31.76 | 2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $27.95 | 2025 | |
| Organon LLC | $20.43 | 2024 | |
| Therapeuticsmd, INC. | $15.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alia Rezek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.